How Much Did DexCare Raise?
Funding & Key Investors

DexCare, a health system capacity management platform-as-a-service (PaaS) provider, has secured significant enterprise-level funding, with its total capital raised standing at $70M. The company recently announced a major strategic investment of $50M, underscoring its pivotal role in optimizing healthcare operations. This latest financing round signifies a crucial phase of growth for DexCare, likely enabling further expansion and technological advancement in the competitive health tech landscape.

What is DexCare?

DexCare
SoftwareHealthcare Software

Based in Seattle, WA, DexCare operates as a health system capacity management platform-as-a-service (PaaS). The company provides solutions designed to enhance the efficiency and effectiveness of healthcare delivery by managing and optimizing the capacity of health systems. This strategic focus addresses critical challenges within the healthcare industry, such as patient wait times, resource allocation, and operational bottlenecks, positioning DexCare as a key player in health tech innovation.

How much funding has DexCare raised?

DexCare has raised a total of $70M across 2 funding rounds:

2021

Series A

$20M

2022

Series B

$50M

Series A (2021): $20M with participation from Kaiser Permanente Ventures, Providence Ventures, Frist Cressey Ventures, Define Ventures Management, and SpringRock Ventures

Series B (2022): $50M led by Define Ventures Management, SpringRock Ventures, Mass General Brigham, Kaiser Permanente, Providence Ventures, Frist Cressey Ventures, and Transformation Capital

Key Investors in DexCare

Define Ventures Management

Define Ventures is an early-stage venture capital firm specializing in digital health companies, indicating a focus on innovative healthcare technology solutions.

SpringRock Ventures

SpringRock Ventures is an investment firm focused on the convergence of healthcare and information technology, targeting high-growth potential companies in sectors like SAAS and services.

Mass General Brigham

Mass General Brigham is a leading integrated healthcare system dedicated to advancing patient care, medical research, and professional education, suggesting a strategic interest in operational efficiency technologies.

What's next for DexCare?

With substantial backing, DexCare is poised for accelerated growth and market penetration. The recent major strategic investment suggests a strong validation of its business model and future potential. This capital infusion will likely fuel product development, expand its service offerings, and strengthen its market presence. DexCare's trajectory indicates a move towards scaling its operations to meet the increasing demand for efficient healthcare management solutions, potentially solidifying its position as a leader in the health system capacity management sector.

See full DexCare company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Healthcare SoftwareSoftwareBusiness ServicesSoftware Testing
Security SoftwareSoftware
Financial SoftwareSoftwareStorage & System Management Software
Engineering SoftwareSoftwareBusiness ServicesSoftware Testing

Frequently Asked Questions Regarding DexCare Financial Insights

What are the most recent funding rounds that DexCare has completed, and what were the funding rounds?
DexCare has recently completed 2 funding rounds: Series B on Jan 13, 2022, Series A on Mar 22, 2021.
What is the total amount of funding DexCare has raised to date?
DexCare has raised a total of $70M in funding to date.
How many funding rounds has DexCare completed?
DexCare has completed 2 funding rounds.
How much funding did DexCare raise in its most recent funding round?
DexCare raised $50M in its most recent funding round.
Who are the lead investors in DexCare's latest funding round?
The lead investor in DexCare's latest funding round was Define Ventures Management. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in DexCare's history?
The largest funding round in DexCare's history was $50M.
See more information about DexCare